Katherine Barnett Peters MD, PhDAssociate Professor of Neurology, Duke University School of Medicine; Program Director, Neuro-Oncology Fellowship Program, Duke, Durham, North Carolina
Dr. Katherine Peters is Associate Professor of Neurology at Duke University School of Medicine in Durham, North Carolina. She is also the Program Director for the Neuro-Oncology Fellowship Program at Duke. Her research interests are in the areas of neurocognition, function, and quality of life in brain tumor patients. Currently, she is managing and running primary clinical trials and supportive care trials for patients with primary brain tumors.
After being awarded her medical degree and a PhD in cancer biology from Stanford University, Dr. Peters undertook residency training in neurology at Johns Hopkins University, where she also completed a fellowship in cognitive neurosciences. She then went on to complete a fellowship in neuro-oncology at the Preston Robert Tisch Brain Tumor Center at Duke University Medical Center.Dr. Peters has over 50 articles published in peer-reviewed journals and is a peer reviewer for 15 national and international scientific journals.
Recent Contributions to PracticeUpdate:
- Second Primary Malignancies Among Glioblastoma Survivors
- Chemotherapy in the Management of Central Neurocytoma
- Anti-IDH 1 Vaccine Among Patients With Low-Grade Glioma
- Targeted Therapy for IDH1 Mutant Low-Grade Glioma
- Health-Related Quality of Life in Patients With Primary CNS Tumors
- Outcomes for Elderly Patients With GBM
- BMX-001 in Combination With Temozolomide Plus Radiation Therapy for Patients With High-Grade Gliomas
- Supportive Care and Quality of Life in Patients With Brain Tumors
- Gene Therapy for GBM: New Data and Perspectives From SNO 2017
- Updated Recommendations for Primary CNS Lymphoma